Experienced healthcare technology leader to drive company's next phase of growth CAESAREA, Israel , Aug. 19, 2024 /PRNewswire/ -- Nitinotes, developers of EndoZipTM, a fully automated endoscopic suturing system aimed at treating obesity, today announced the appointment of Lloyd Diamond as the Chief Executive Officer, effective immediately. Mr.
Diamond brings more than 30 years of leadership in the medical device industry, having spearheaded significant advancements in orthopedics, endoscopic, and general surgical devices. Most recently, he served as CEO of Pixium Vision S.A.
, where he led the development of groundbreaking bionic vision systems and strategic partnerships. "We are thrilled to welcome Lloyd to lead Nitinotes into its next chapter of innovation and growth," said John Barr , Chairman of the Board. "Building upon the foundation established and the exceptional achievements attained, his extensive experience in medical technologies positions him as an outstanding leader to advance our future initiatives.
" Lloyd succeeds Raz Bar-On , who will continue as GM of Nitinotes Israel, overseeing operations, R&D, and regulatory functions. "I am honored to join Nitinotes at this pivotal time," said Lloyd Diamond . "With obesity rates rising worldwide and over 1 billion people affected, EndoZipTM provides a critical solution to a significant global health challenge.
I look forward to working with the talented team to bring this solution to more patients and healthcare providers.